Physician profile
Daniel Park
NPI 1558866798
$2,139.85
in general payments reported to CMS, 2019-2025
17 companies · $954 in 2025
The $954 reported for 2025 was more than what 76% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $193 · 2023: $617 · 2024: $377 · 2025: $954.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,947.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,946.94 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $883.65 | 2023-2025 | |
| Alcon Vision LLC | $168.12 | 2025 | Hydrus Microstent, Rocklatan |
| Bausch & Lomb Americas INC. | $165.33 | 2022-2023 | Vyzulta |
| Nova Eye, INC. | $130.30 | 2024-2025 | |
| Alimera Sciences, INC. | $125.00 | 2022 | |
| New World Medical,INC. | $112.05 | 2023 | |
| Intuitive Surgical, INC. | $98.22 | 2023 | Da Vinci Surgical System |
| Sun Pharmaceutical Industries INC. | $79.48 | 2024-2025 | |
| Tarsus Pharmaceuticals, INC. | $62.57 | 2024-2025 | Xdemvy |
| Rxsight INC | $61.85 | 2024-2025 | Rxsight Injector Cartridge, Light Adjustable Lens (Lal), Rxsight Contact Lens |
| Pharmaessentia USA Corporation | $61.53 | 2025 | Besremi |
| Carl Zeiss Meditec USA, INC. | $48.54 | 2025 | Forum |
| Thea Pharma INC. | $41.55 | 2025 | Iyuzeh |
| Deciphera Pharmaceuticals INC. | $29.45 | 2025 | Romvimza, Qinlock |
| Array Biopharma INC | $27.69 | 2025 | Lorbrena |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $22.93 | 2025 | Tepezza |
| Oyster Point Pharma, INC. | $21.59 | 2025 | Tyrvaya |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Park listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.